Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Carina Blomström-Lundqvist
Job title: Professor of Cardiology
Dr Carina Blomström-Lundqvist is Professor of Cardiology at the Department of Cardiology, Institution of Medical Science, Uppsala, SE and Senior Consultant and Professor at the Department of Cardiology and Medical Science, Örebro University Hospital, Örebro, SE. Dr Blomström-Lundqvist graduated in medicine in 1976, she went on to specialise in cardiology and internal medicine, and started… View more
Omron logo
Omron Healthcare is a manufacturer of medical equipment for therapy and health monitoring. Our range of products includes blood pressure monitors, portable ECG, augmentation index device, respiratory therapy devices, electronic fever thermometers and body fat monitors among others. Our eco-friendly products are not only known for their high quality and performance standards, but also for their… View more
Dr Eva Prescott
Research Area(s) / Expertise:

Cardiac Rehabilitation Programmes

 Job title: Professor at Bispebjerg Hospital, Department of Cardiology, Copenhagen, Denmark
Academic History Dr Eva Prescott studied at Greve Gymnasium in Greve, Denmark from 1977 to 1980. Later on, she became an MD at the University of Copenhagen, where she studied from 1981 to 1990. Career Overview Dr Prescott leads the Centre for Cardiovascular Research at Bispebjerg Frederiksberg University Hospital, Copenhagen. Her main research areas include angina pectoris, cardiac… View more
Job title: Director of the Cardiometabolic Program
Metabolite Profile Predicts Future Type 2 Diabetes Risk
Added: 2 months ago Source:  Radcliffe CVRM
The human metabolome reflects a complex interplay of genetic and environmental factors. A large-scale analysis integrating blood metabolomic, genomic, and lifestyle data from ten prospective cohorts has identified a comprehensive profile of circulating metabolites that are associated with the future risk of developing type 2 diabetes (T2D).¹MethodologyResearchers conducted a pooled analysis of 23… View more
Treatment Options and Continuity of Care in MAFLD
Author(s): Carmen Lara-Romero , Manuel Romero-Gómez Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Obesity in the Asia-Pacific Region: Current Perspectives
Author(s): David Tak Wai Lui , Junya Ako , Jamshed Dalal , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood Pressure Control
Added: 1 year ago Source:  Radcliffe Cardiology
AUTHOR: David RamseyAmerican Diabetes Scientific Sessions, 23 June 2024 – The data from three studies investigating glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonists in patients with obesity was recently presented at a late-breaking session at the American Diabetes Association’s 84th Scientific Sessions in Orlando… View more

Prevention & Chronic Conditions
Metabolome-Informed BMI Better Predicts CVRM Risk
Added: 3 months ago Source:  Radcliffe CVRM
A new study has defined a metabolome-informed body mass index (metBMI) that more accurately reflects adiposity and cardiometabolic risk than the traditional BMI calculation.² The findings, published in Nature Medicine, suggest this multi-omic approach could help identify high-risk individuals whose metabolic dysfunction is not captured by conventional measures.¹MethodologyResearchers developed… View more

Cardiovascular Kidney Metabolic

Digital Health
Olezarsen Cuts Triglycerides and Pancreatitis Risk
Added: 5 months ago Source:  Radcliffe CVRM
For patients with severe hypertriglyceridemia, monthly treatment with olezarsen significantly reduced triglyceride levels and the incidence of acute pancreatitis compared with placebo, according to findings from two pivotal trials, CORE-TIMI 72a and CORE2-TIMI 72b.¹Olezarsen is an antisense oligonucleotide designed to inhibit the production of apolipoprotein C-III (ApoC-III), a key protein in the… View more

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions